Interview with Colin Edwards, General Manager, Boehringer Ingelheim Ireland
Dr. Edwards, you have been both a lecturer and a researcher. What made you ‘come over to the dark side’ and become a manager? I do not find it to…
Address: The Hyde Building,
4th Floor,
The Park, Carrickmines. Dublin 18 ,Ireland
Tel: 353 1 291-3904
Web: http://www.boehringer-ingelheim.ie/
Boehringer Ingelheim is a global group of companies, one of the world’s 20 leading pharmaceutical corporations.
Our mission is to improve the health and well being of people and animals through being a part of an independent, innovative, research and development driven company.
We have an excellent reputation for providing effective products for the treatment of respiratory disease, cardiovascular disease, HIV, Parkinson’s disease, thromboembolic disease, cerebrovascular disease and depression.
Dr. Edwards, you have been both a lecturer and a researcher. What made you ‘come over to the dark side’ and become a manager? I do not find it to…
Mr. O’Leary, when an article in The Guardian last year profiled you and your work, it was titled “Resurrecting the Celtic Tiger.” More recently, Time Magazine put Taoiseach Enda Kenny…
To what extent do you believe Ireland has been successful in building the knowledge economy it set out to create during the 1980’s? I think we have been hugely successful—and…
You noted that, in the ‘old days’, the pharma business had the following characteristics: first of all, it was a molecule-driven business, fueled by blockbuster medicines that met robust medical…
Dr. McLoughlin, you were appointed to your post in April of this year. Can you please give us an impression of what you inherited at this Department when you took…
Dr. Mitchell, what attracted you to join Novartis after a decades-long career at Astrazeneca? If you had told me a year ago that I would leave the company I’d worked…
Dr. Duffy, how has Pfizer’s investment in Ireland evolved over time? Pfizer began operating in Ireland in the late 1960’s, making citric acid which is an ingredient that can be…
Mr. Zimmermann, you came to manage the Irish affiliate of Bayer in 2010, after heading Business Management for Bayer Pharma Headquarters in Berlin. After these two years, what are your…
Prof. Ferguson, when you were recently appointed to direct SFI, local newspapers ran headlines such as “New SFI head to drive economic impact from research investments.” What do you understand…
Mr. Timmons, when we interviewed your colleague at Takeda Products Ireland, Mr. Kieran Leahy, he mentioned that you have a very interesting professional history. Can you begin by telling us…
Mr. Leahy, you worked for Servier for nearly a decade before joining Takeda. What have been the chief differences you have noticed between the smaller, independent, French player, and the…
With an evident recession and cost-cutting measures abound Ms. Nolan elaborates on the new plain on which pharmaceutical players have found themselves upon and how they have adjusted to the…
Novo Nordisk is primarily known as the premier global diabetes player—so let us begin by examining the realities of diabetes in Ireland. In 2012, the International Diabetes Federation estimated that…
See our Cookie Privacy Policy Here
